Effects of Resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced Oxidative Events and Gene Expression in Mouse Skin
Overview
Authors
Affiliations
Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural product shown to inhibit carcinogen-induced pre-neoplastic lesions in mouse mammary organ culture and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted mouse skin tumors. Application of TPA to mouse skin induces oxidative stress, as evidenced by numerous biochemical responses, including significant generation of H2O2 and enhanced levels of myeloperoxidase and oxidized glutathione reductase activities and decreases in glutathione levels and superoxide dismutase activity. TPA treatment also elevates the expression of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), c-myc, c-fos, c-jun, transforming growth factor-beta1 (TGF-beta1) and tumor necrosis factor-alpha (TNF-alpha). As currently reported, pre-treatment of mouse skin with resveratrol negated several of these TPA-induced effects in a dose-dependent manner. H2O2 and glutathione levels were restored to control levels, as were myeloperoxidase, oxidized glutathione reductase and superoxide dismutase activities. As judged by reverse transcriptase-polymerase chain reaction (RT-PCR), TPA-induced increases in the expression of c-fos and TGF-beta1 were selectively inhibited. These data suggest that resveratrol inhibits tumorigenesis in mouse skin through interference with pathways of reactive oxidants and possibly by modulating the expression of c-fos and TGF-beta1.
Resveratrol-Induced Signal Transduction in Wound Healing.
Pignet A, Schellnegger M, Hecker A, Kohlhauser M, Kotzbeck P, Kamolz L Int J Mol Sci. 2021; 22(23).
PMID: 34884419 PMC: 8657598. DOI: 10.3390/ijms222312614.
Chemical diversity of dietary phytochemicals and their mode of chemoprevention.
Patra S, Nayak R, Patro S, Pradhan B, Sahu B, Behera C Biotechnol Rep (Amst). 2021; 30:e00633.
PMID: 34094892 PMC: 8167155. DOI: 10.1016/j.btre.2021.e00633.
The drug likeness analysis of anti-inflammatory clerodane diterpenoids.
Feng Z, Cao J, Zhang Q, Lin L Chin Med. 2020; 15(1):126.
PMID: 33298100 PMC: 7727157. DOI: 10.1186/s13020-020-00407-w.
Selective antagonism of cJun for cancer therapy.
Brennan A, Leech J, Kad N, Mason J J Exp Clin Cancer Res. 2020; 39(1):184.
PMID: 32917236 PMC: 7488417. DOI: 10.1186/s13046-020-01686-9.
Costa-Machado L, Fernandez-Marcos P Cell Cycle. 2019; 18(18):2164-2196.
PMID: 31251117 PMC: 6738532. DOI: 10.1080/15384101.2019.1634953.